Corporate Press ReleaseStrides receives USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mgNewsmantraSeptember 6, 2024 by NewsmantraSeptember 6, 20240 Strides is the “first approved applicant” and is eligible for 180 days of Competitive Generic...
